Sergio Marchini

6.1k total citations
105 papers, 3.6k citations indexed

About

Sergio Marchini is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sergio Marchini has authored 105 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 40 papers in Cancer Research and 30 papers in Oncology. Recurrent topics in Sergio Marchini's work include Cancer-related molecular mechanisms research (17 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cancer Genomics and Diagnostics (14 papers). Sergio Marchini is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cancer Genomics and Diagnostics (14 papers). Sergio Marchini collaborates with scholars based in Italy, United States and Spain. Sergio Marchini's co-authors include Maurizio D’Incalci, Massimo Broggini, Luca Beltrame, Raffaella Giavazzi, Giulia Taraboletti, Chiara Romualdi, Robert Fruscio, Glynn Faircloth, Dorina Belotti and Luigi Manenti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sergio Marchini

102 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergio Marchini Italy	33	2.0k	1.3k	970	515	321	105	3.6k
Paweł Surowiak Poland	32	2.3k 1.1×	930 0.7×	1.3k 1.3×	622 1.2×	199 0.6×	97	3.7k
Gong Yang China	45	2.8k 1.4×	1.5k 1.1×	1.4k 1.5×	461 0.9×	407 1.3×	108	5.0k
Bassem R. Haddad United States	33	2.4k 1.2×	718 0.6×	1.0k 1.0×	466 0.9×	148 0.5×	81	4.4k
J. Chuck Harrell United States	35	1.9k 1.0×	1.1k 0.9×	1.8k 1.9×	467 0.9×	145 0.5×	78	3.6k
Claudio Festuccia Italy	45	2.8k 1.4×	1.1k 0.8×	1.6k 1.7×	1.1k 2.2×	98 0.3×	164	5.3k
Heidi Sowter United Kingdom	23	2.6k 1.3×	1.9k 1.5×	551 0.6×	488 0.9×	100 0.3×	28	3.8k
Pixu Liu China	23	3.1k 1.5×	731 0.6×	1.2k 1.2×	563 1.1×	127 0.4×	44	4.4k
Ming-Derg Lai Taiwan	32	1.5k 0.7×	532 0.4×	519 0.5×	233 0.5×	177 0.6×	70	2.8k
Sophie Vacher France	39	2.6k 1.3×	1.5k 1.1×	1.5k 1.5×	587 1.1×	68 0.2×	142	4.5k
Cen Zhang United States	34	3.2k 1.6×	2.4k 1.9×	1.5k 1.6×	603 1.2×	65 0.2×	58	4.8k

Countries citing papers authored by Sergio Marchini

Since Specialization

Citations

This map shows the geographic impact of Sergio Marchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Marchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Marchini more than expected).

Fields of papers citing papers by Sergio Marchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Marchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Marchini. The network helps show where Sergio Marchini may publish in the future.

Co-authorship network of co-authors of Sergio Marchini

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Marchini. A scholar is included among the top collaborators of Sergio Marchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Marchini. Sergio Marchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mikulak, Joanna, Rocco Piazza, Domenico Vitobello, et al.. (2025). Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics. Cell Death and Disease. 16(1). 229–229. 2 indexed citations

Beltrame, Luca, et al.. (2024). Integrated approach to generate artificial samples with low tumor fraction for somatic variant calling benchmarking. BMC Bioinformatics. 25(1). 180–180.

Craparotta, Ilaria, Laura Mannarino, Sergio Marchini, et al.. (2024). Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites. Journal of Experimental & Clinical Cancer Research. 43(1). 309–309.

Beltrame, Luca, et al.. (2023). A pan-cancer landscape of pathogenic somatic copy number variations. Journal of Biomedical Informatics. 147. 104529–104529. 2 indexed citations

Pesenti, Chiara, Luca Beltrame, Robert Fruscio, et al.. (2022). Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis. European Journal of Cancer. 171. 85–95. 13 indexed citations

Nagaraj, Anil Belur, Sreeja C. Sekhar, Peronne Joseph, et al.. (2021). The miR–181a–SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer. Cancer Research. 81(8). 2044–2055. 45 indexed citations

Todeschini, Paola, Elisa Salviato, Chiara Romani, et al.. (2021). Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers. 13(13). 3358–3358. 16 indexed citations

Paracchini, Lara, Luca Beltrame, Tommaso Grassi, et al.. (2020). Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer. Clinical Cancer Research. 27(9). 2549–2559. 38 indexed citations

Liguori, Manuela, Elisabeth Digifico, Federico Colombo, et al.. (2020). The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33. Cellular and Molecular Immunology. 18(3). 711–722. 89 indexed citations

10.

Romani, Chiara, Valentina Zizioli, Marco Silvestri, et al.. (2020). Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients. Frontiers in Oncology. 10. 1287–1287. 11 indexed citations

11.

Frapolli, Roberta, Ezia Bello, Ilaria Craparotta, et al.. (2019). Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. Clinical Cancer Research. 25(24). 7565–7575. 20 indexed citations

12.

Hollander, Lital, Diego Cortinovis, Irene Floriani, et al.. (2015). ATREUS Trial: A Phase II Study On The Activity Of Trabectedin In Pretreated Epithelioid Or Biphasic/Sarcomatoid Malignant Pleural Mesothelioma (MPM). Annals of Oncology. 26. vi87–vi87. 1 indexed citations

13.

Marchini, Sergio, Elizabeth Poynor, Richard R. Barakat, et al.. (2012). The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer. Clinical Cancer Research. 18(16). 4313–4324. 39 indexed citations

14.

Marchini, Sergio, Robert Fruscio, Luca Clivio, et al.. (2012). Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer. European Journal of Cancer. 49(2). 520–530. 146 indexed citations

15.

Scarpati, Giuseppina Della Vittoria, Francesca Falcetta, Chiara Carlomagno, et al.. (2011). A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(4). 1113–1119. 140 indexed citations

16.

Marchini, Sergio, Giovanna Chiorino, Riccardo Bonomi, et al.. (2008). Analysis of Gene Expression in Early-Stage Ovarian Cancer. Clinical Cancer Research. 14(23). 7850–7860. 30 indexed citations

17.

Marchini, Sergio, et al.. (2005). Gene expression analysis of Manumycin, a natural farnesyltransferase (FTase) inhibitor, in drug-resistant IL-6-producing myeloma cells.. Cancer Research. 65. 14–14. 3 indexed citations

18.

Marabese, Mirko, Sergio Marchini, Maria Antonietta Sabatino, et al.. (2005). Effects of inducible overexpression of DNp73α on cancer cell growth and response to treatment in vitro and in vivo. Cell Death and Differentiation. 12(7). 805–814. 17 indexed citations

19.

Marchini, Sergio, Massimo Broggini, Cristiana Sessa, & Maurizio D’Incalci. (2001). Development of distamycin-related DNA binding anticancer drugs. Expert Opinion on Investigational Drugs. 10(9). 1703–1714. 36 indexed citations

20.

Marchini, Sergio, Janet S. Rader, Alonso Martínez, et al.. (1999). Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.. PubMed. 59(18). 4662–7. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact